GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

910.87

804.98

953.38

738.02

782.16

Operating profit

255.31

217.51

286.58

141.25

166.76

Interest

0.77

0.32

0.43

0.28

0.65

Gross profit

284.41

245.53

314.62

177.77

194.08

EPS (Rs)

11.40

2.69

12.72

7.71

7.76

Other income

29.87

28.34

28.47

36.80

27.97

Stock adjustment

-98.90

63.93

9.71

-44.38

69.34

Raw material

192.29

87.52

79.71

145.47

95.70

Power and fuel

-

-

-

-

-

Employee expenses

172.83

141.35

145.21

165.00

148.84

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

389.34

294.67

432.17

330.68

301.52

Provisions made

-

-

-

-

-

Depreciation

18.10

17.11

18.11

16.36

17.18

Taxation

75.63

19.62

80.97

48.13

55.82

Net profit / loss

193.08

45.49

215.54

130.58

131.48

Extra ordinary item

2.40

-163.31

-

17.30

10.40

Prior year adjustments

-

-

-

-

-

Equity capital

169.41

169.41

169.41

169.41

169.41

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.03

27.02

30.06

19.14

21.32

GPM (%)

30.23

29.46

32.04

22.94

23.96

NPM (%)

20.52

5.46

21.95

16.85

16.23